Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.40 |
| ▸ | GABRE | P78334 | 1/20 | 0.40 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.40 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.40 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.40 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.40 |
| ▸ | PLK4 | O00444 | 1/20 | 0.40 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26267001 | 0.79 | METAP1 (0.40) | KDM4EMAPTRAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL26267000 | 0.79 | METAP1 (0.40) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL26267037 | 0.78 | CCR1 (0.33) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL26267002 | 0.78 | ACHE (0.35) | ALDH1A1ADRA2AADRA1ATYMS | |
| SCHEMBL26266999 | 0.77 | HTR5A (0.33) | MAPTSMN1; SMN2ALDH1A1HPGDKMT2A | |
| SCHEMBL26267016 | 0.75 | — | — | |
| SCHEMBL16369460 | 0.75 | PNMT (0.39) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL26267009 | 0.73 | AKT1 (0.36) | — | |
| SCHEMBL26266786 | 0.72 | TDP2 (0.32) | — | |
| SCHEMBL18416164 | 0.71 | GABRP (0.36) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018037-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| US-20230371359-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-11-16 | — | — | US | disclosed |
| US-11758803-B2 | Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-09-12 | — | — | US | disclosed |
| US-20230276692-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-31 | — | — | US | disclosed |
| US-20230276693-A1 | LIGHT-EMITTING DEVICE, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND MIXTURE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-31 | — | — | US | disclosed |
| US-11731994-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-20150008419-A1 | MICROCAVITY OLED DEVICE WITH NARROW BAND PHOSPHORESCENT EMITTERS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2015-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11731994-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | CYBA, CYC1, C1S | GABRP 4699/4885GABRD 4852/4885GABRA1 4501/4885 |
| US-20230371359-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | L1CAM, MSL1, EML4 | GABRP 4802/4885GABRD 4712/4885GABRA1 3976/4885 |
| US-11758803-B2 | Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device | L1CAM, MSL1, EML4 | GABRP 4802/4885GABRD 4712/4885GABRA1 3976/4885 |
| US-12018037-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | ORC3, LEF1, OCIAD1 | GABRP 4187/4885GABRD 4034/4885GABRA1 3097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.